Advik Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve notice is hereby given that ....
Awaiting price reaction for this filing.
MPS Pharmaa Limited (formerly Advik Laboratories Limited) has informed BSE about a Board meeting scheduled for 28th May, 2026 at 12:00 PM at their Corporate Office in New Delhi. The meeting will consider and approve the Audited Financial Results for the quarter and Financial Year ended 31st March, 2026. Additionally, the Board will consider appointing M/s Sanghi & Co., Chartered Accountants as the Internal Auditor for FY 2026-27. The trading window for insiders is already closed and will remain so till 30th May, 2026.
This is a routine pre-results announcement filing. The appointment of a new internal auditor (Sanghi & Co.) suggests a change in audit arrangements. Actual impact on shareholders will depend on the financial results to be declared on 28th May.